Explore evidence

The Delta variant (B.1.617) circulated during the third wave of COVID-19 in Gabon.

GabonB.1.617 · COVID-19published 2022Frontiers in medicineeurope_pmcdocument of 13 observationsDOI 10.3389/fmed.2022.877391

167 patientsAmong 305 surveyed patients with COVID-19, 167 (55%) were on co-medications that did not prohibit but posed a risk of adverse interactions with hydroxychloroquine.

GabonCOVID-19published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 8 observations

12 %Asthma represented 12% of recorded chronic diseases among SARS-CoV-2 infected subjects.

Gabonasthme · COVID-19published 2021Scientific reportseurope_pmcdocument of 23 observations

55 %55% of SARS-CoV-2 RT-PCR confirmed negative contact-cases were positive for anti-SARS-CoV-2 antibodies.

GabonCOVID-19published 2021Scientific reportseurope_pmcdocument of 23 observations

3.7 %Among 837 patients with COVID-19 in Gabon from March to June 2020, 31 (3.7%) had severe symptoms.

GabonCOVID-19observed March to June 2020published 2021JAMA network openPubMeddocument of 10 observations

21.3 %QTc prolongation exceeding 60 ms was found in 48 (21.3%) patients.

GabonCOVID-19published 2022Clinics and practiceeurope_pmcdocument of 5 observations

281 deathsAs of December 8, 2021, Gabon reported 281 deaths due to COVID-19.

GabonCOVID-19observed December 8, 2021published 2022Frontiers in medicineeurope_pmcdocument of 13 observationsDOI 10.3389/fmed.2022.877391

Among 26 severe COVID-19 cases treated with azithromycin plus a second antibiotic at the Regional Hospital of Lambaréné, 24 were cured without sequelae, 1 had sequelae, and 1 died.

GabonCOVID-19observed 2020published 2022Medecine tropicale et sante internationalePubMeddocument of 6 observations

The third wave of COVID-19 in Gabon occurred from September 2021 to November 2021.

GabonCOVID-19observed September 2021 to November 2021published 2022Frontiers in medicineeurope_pmcdocument of 13 observationsDOI 10.3389/fmed.2022.877391

14.7 %Among 809 SARS-CoV-2 samples screened by qRT-PCR in Gabon from March 2020 to September 2021, 119 (14.7%) were classified as VOC Alpha (B.1.1.7).

GabonB.1.1.7 · COVID-19 · VOC Alphaobserved March 2020 to September 2021published 2022Frontiers in medicineeurope_pmcdocument of 13 observationsDOI 10.3389/fmed.2022.877391

5 patientsFive out of eight patients with malaria and COVID-19 co-infection had respiratory discomfort.

GabonCOVID-19 · paludismepublished 2022The Pan African medical journalPubMeddocument of 6 observations

The first COVID-19 case in Gabon was reported on March 12, 2020.

GabonCOVID-19observed March 12, 2020published 2022Frontiers in medicineeurope_pmcdocument of 13 observationsDOI 10.3389/fmed.2022.877391

91.78 %The seroprevalence of SARS-CoV-2 antibodies in the 20-29 age group in Gabon was 91.78% (95% CI: 89.5–93.6).

GabonCOVID-19observed up to December 2021published 2024Viruseseurope_pmcdocument of 5 observations

The first case of COVID-19 in Gabon was diagnosed on March 12, 2020.

GabonCOVID-19observed March 12 2020published 2022F1000Researcheurope_pmcdocument of 2 observationsDOI 10.12688/f1000research.74378.2

2.8 %Only 2.8% of participants knew the pathogenic agent responsible for COVID-19.

GabonCOVID-19published 2021Knowledge, Attitude, and Practice During the COVID-19 Pandemic in South-east Gabon.europe_pmcdocument of 11 observationsDOI 10.21203/rs.3.rs-299801/v1

25 %Diabetes represented 25% of recorded chronic diseases among SARS-CoV-2 infected subjects.

GabonCOVID-19 · diabète (non précisé)published 2021Scientific reportseurope_pmcdocument of 23 observations

1.26 aORLater stages of the pandemic were dominated by clade GRA, which disproportionately affected children (0–9 years) with an adjusted odds ratio of 1.26.

Gabonclade GRA · COVID-19observed later stagespublished 2026Viruseseurope_pmcdocument of 5 observations